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It is a great pleasure to be allowed to share with the readers 
of the Journal my personal view of Sir James Black, Nobel 
Laureate 1988 for physiology or medicine (Fig. 1). There are 
not too many members of the College who can call them- 
selves a Nobel Prize winner. Dr. Black’s Honorary Fellow- 
ship Award in 1984 was neither the first nor the last scientific 
distinction that he received. Dr. Dennis Krikler was Dr. 
Black’s marshal at the 33rd Annual Meeting of the College, 
and it is generally perceived that few members of our 
generation have done more for mankind than Dr. Black. 
Many people know Dr. Black’s accomplishments, but 
few know the man. I am privileged to have known Dr. Black 
for close to 30 years, and after our first meeting in late 
November 1959, we and our families became close friends. 
We were both young then, Dr. Black worked as a scientist 
for Imperial Chemical Industries (ICI) near Macclesfield in 
Great Britain. At that time I was a research fellow working 
with the also young Professor Dirk Durrer in Amsterdam. In 
Dr. Durrer’s laboratory we needed a magnetic flow meter to 
study the relation between arrhythmias and arterial flow. Dr. 
Black was the first in Europe to purchase such a device, so 
I went to see him and his flow meter. I was a guest at his 
home, and that first night while we walked together in the 
rain he told me about his work and the compound that he 
was about to develop. I had never heard of Ahlquist (1) or of 
the concept of alpha and beta adrenoreceptors, let alone that 
those receptors could be blocked with molecules that would 
be taken up by mistake, as it were (2). Dr. Black’s vast 
knowledge and understanding of biology and chemistry 
enabled him to come up with this concept and to predict how 
the drug would actually work before he had even made it. 
That night Dr. Black predicted that his new compound 
would relieve the pain of angina pectoris and would become 
the drug of choice in the treatment of hypertension. This 
is how he started. Ten years later history repeated itself 
with the development of the histamine H, receptor antag- 
onist (3). Dr. Black told me then he knew that this approach 
Figure 1. Dr. Black in scientific action. 
would put an end to most gastric or duodenal surgery, or 
both. 
The two new families of drugs that he developed provided 
the industries for which he worked with sales of more than 
$5 billion a year, but he himself never received a dime and, 
interestingly, he did not care. Dr. Black’s profit was that his 
brainchildren lived a prosperous and healthy life and that 
numerous patients benefited from his work. 
Dr. Black is a brilliant man and a nonconformist in many 
ways, not only in relation to science. He never cared, for 
instance, for the high life of British society, nor did he 
pursue wealth or fame. He has a keen eye for the political 
systems in our part of the world, though, and a decade ago 
he told me that we are borrowing money from our children. 
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His unrestrained honesty is refreshing. He profoundly 
dislikes, and for good reasons, anonymous reviews of scien- 
tific papers. He loves art, music and literature, and reads 
widely beyond his own direct field of interest. He is a true 
and trusted friend, a wonderful and warm person who will 
help anybody who needs him. 
01989 by the American College of Cardiology 0735-1097/89/$3.50 
770 MEIJLER JACC Vol. 13, No. 3 
ACC NEWS March 1, 1989:769-70 
Sir James is a modest if not a shy man. His Nobel Prize he 
called “a wonderful disaster,” and I am sure that when he 
faces the King of Sweden to receive the highest scientific 
award, which he deserves more than almost anyone (4), he 
will wish himself to be invisible. The tears in his eves will be 
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